These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 13727585)

  • 1. Carcinostatic liver factor. I. Effect in vitro of homologous liver extracts on viability of Ehrlich ascites carcinoma cells.
    NAKAHARA W; FUKUOKA F
    Gan; 1961 Jun; 52():197-202. PubMed ID: 13727585
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental studies on growth-promoting and growth-inhibiting substances of malignant tumor. 3. Carcinostatic effect of extracts from human leiomyosarcoma and spleen, and bovine liver.
    Sugihara Y; Araki F
    Hiroshima J Med Sci; 1964 Dec; 13(3):299-310. PubMed ID: 5890751
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition in vitro of growth of rat ascites tumor cells by bovine liver extract. Purification and property of the active principle.
    HORI M; UKITA T
    J Biochem; 1962 May; 51():322-34. PubMed ID: 14448892
    [No Abstract]   [Full Text] [Related]  

  • 4. Carcinostatic liver factor. II. Discrimination from liver ribonucleic acid.
    NAKAHARA W; FUKUOKA F; NAORA H
    Gan; 1962 Mar; 53():1-5. PubMed ID: 14478104
    [No Abstract]   [Full Text] [Related]  

  • 5. [Interference with the activity of some dehydrogenases in intact cells of Ehrlich ascites carcinoma (EAC) as 1 of the criteria in the investigation of carcinostatic antibiotics and other drugs].
    DROBNICA L
    Neoplasma; 1960; 7():385-91. PubMed ID: 13724433
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of a basic liver protein fraction on KB and Ehrlich ascites tumor cells.
    Comoroşan S; Stănescu M; Solomon S; Gaşpar A; Vieru S; Sandru D; Soldatu M
    Arch Geschwulstforsch; 1967; 28(4):320-7. PubMed ID: 5594755
    [No Abstract]   [Full Text] [Related]  

  • 7. QUANTITATIVE STUDIES ON THE FRACTIONATION OF CARCINOSTATIC LIVER FACTOR.
    HOZUMI M; SUGIMURA T; FUKUOKA F; NAKAHARA W
    Gan; 1963 Sep; 54():281-8. PubMed ID: 14064010
    [No Abstract]   [Full Text] [Related]  

  • 8. Biological inhibitor of transplantable mouse tumors.
    Miller AJ; Kimsey LS
    Cancer; 1967 Apr; 20(4):471-7. PubMed ID: 6019821
    [No Abstract]   [Full Text] [Related]  

  • 9. ISOLATION AND CHARACTERIZATION OF CARCINOSTATIC LIVER FACTORS ACTIVE IN VITRO.
    TSUDA M; YOSHIOKA Y; KATAOKA N; TACHIBANA M; MAEDA Y; UEHARA N; KAWAZOE Y; CHIHARA G; NAKAHARA W
    Gan; 1965 Feb; 56():69-74. PubMed ID: 14326035
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro test for sensitivity of tumor to carcinostatic agents.
    Kondo T; Imamura T; Ichihashi H
    Gan; 1966 Apr; 57(2):113-21. PubMed ID: 4289605
    [No Abstract]   [Full Text] [Related]  

  • 11. The growth-inhibiting substances in liver extract of rats for rat ascites hepatoma cells in tissue culture.
    SUZUKI S
    Jpn J Exp Med; 1959 Aug; 29():241-53. PubMed ID: 13835884
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies with ascites tumors in experimental chemotherapy. II. Performance in a screening situation.
    SASSENRATH EN; COSTA FM; GREENBERG DM
    Cancer Chemother Rep; 1961 Apr; 11():13-28. PubMed ID: 13746675
    [No Abstract]   [Full Text] [Related]  

  • 13. [Influence of nicotinamide on the DPN-content, glycolysis and viability of ascites tumor cells after treatment with carcinostatic ethyleneimine compounds].
    MIELSCH M; GRIMBERG H; DOLD U; HOLZER H
    Biochim Biophys Acta; 1962 Aug; 62():519-24. PubMed ID: 14473575
    [No Abstract]   [Full Text] [Related]  

  • 14. A new carcinostatic agent for the Ehrlich ascites tumor.
    FURST A; MILLER J; GROSS H; CUTTING W
    Acta Unio Int Contra Cancrum; 1960; 16():625-7. PubMed ID: 13825720
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative analysis of inductive agents in rat normal liver and ascites hepatoma.
    KAWAKAMI I; IYEIRI S
    J Exp Zool; 1962 Mar; 149():117-25. PubMed ID: 14454564
    [No Abstract]   [Full Text] [Related]  

  • 16. Presence of a tumor inhibitory principle in livers.
    HERBUT PA; KRAEMER WH
    Am J Pathol; 1960 Jan; 36(1):105-11. PubMed ID: 14401229
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro inactivation of endotoxin by an intracellular agent from rabbit liver.
    TRAPANI RJ; WARAVDEKAR VS; LANDY M; SHEAR MJ
    J Infect Dis; 1962; 110():135-42. PubMed ID: 13922292
    [No Abstract]   [Full Text] [Related]  

  • 18. [The hydration 2,5-bis-n-propoxy-3,6-bisethylaminobenzoquinone (1,4) (Bayer E 39) in Ehrlich ascites tumor cells].
    FRIMMER M
    Med Exp Int J Exp Med; 1960; 3():135-9. PubMed ID: 13702110
    [No Abstract]   [Full Text] [Related]  

  • 19. [Description of highly purified glutamic-pyruvic transaminase from dog liver and its effect on the anaerobic glycolysis of the Ehrlich mouse ascites carcinoma cell].
    Noll F
    Z Naturforsch B; 1966 Jan; 21(1):59-62. PubMed ID: 4382385
    [No Abstract]   [Full Text] [Related]  

  • 20. DECREASE OF CARCINOSTATIC LIVER FACTOR IN TUMOR-BEARING ANIMALS.
    HOZUMI M; SUGIMURA T; TATENO Y; FUKUOKA F; NAKAHARA W
    Gan; 1964 Jun; 55():191-5. PubMed ID: 14188563
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.